← Open Payments lookup

NIKKI JOHNSTON: Open Payments

NPI 1528593472 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$357 in 20 payments from 11 companies in 2025. Trend: 2023 $247 · 2024 $272 · 2025 $357

Food & beverage: $343Education: $14
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$69
Mallinckrodt Hospital Products Inc.2$51
Boehringer Ingelheim Pharmaceuticals, Inc.3$44
Novo Nordisk Inc2$42
Fresenius USA Marketing, Inc.2$33
Bayer Healthcare Pharmaceuticals Inc.2$30
Otsuka America Pharmaceutical, Inc.1$21
Calliditas Therapeutics US Inc.1$20
Ardelyx, Inc.1$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$15

Products named: FARXIGA, ACTHAR, JARDIANCE, VELPHORO, Kerendia, JYNARQUE, Rybelsus, Ozempic.

Industry payments across TX — which companies pay providers there.